2,6-Dibromopyrazine

Catalog No. :
ACHPOW357
CAS No. :
23229-25-6
Molecular Formula :
C4H2Br2N2
Molecular Weight :
237.88

IUPAC Name:2,6-dibromopyrazine

2,6-Dibromopyrazine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25g95%$56.00Login to see priceIn stockInquiry
100g95%$221.00Login to see priceIn stockInquiry
500g95%$884.00Login to see priceIn stockInquiry
1000g95%$1415.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2,6-Dibromopyrazine
IUPAC Name2,6-dibromopyrazine
MDL No.MFCD09834804
Molecular FormulaC4H2Br2N2
Molecular Weight237.88
SMILESBrC1=CN=CC(Br)=N1
InChI KeyJXKQTRCEKQCAGH-UHFFFAOYSA-N
Synonym2,6-Dibromopyrazine | 2,6-dibromo-pyrazine | MFCD09834804 | JXKQTRCEKQCAGH-UHFFFAOYSA-N | SY024155 | AB52791 | BCP9000086 | STL555579 | Q-103276 | SCHEMBL4968 | EN300-102678 | AKOS007930819 | D4544 | US10246456, Example 408 | AM20070331 | CS-D1575 | FT-06
CAS No.23229-25-6
PubChem CID20361700

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P264-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P362+P364-P403+P233-P501

Synthetic Route by SureRoute

1. ACHPOW357 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACJSDN037 route compound structure diagram
    ACJSDN0377789-46-0 In Stock
  2. Plus
  3. ACKEJN184 route compound structure diagram
    ACKEJN18454237-53-5 In Stock
  4. Then
  5. ACHPOW357 route product structure diagram
    ACHPOW35723229-25-6 In Stock
Inquiry

2. ACHPOW357 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACHPOW357 route compound structure diagram
    ACHPOW35723229-25-6 In Stock
  4. Then
  5. ACHPOW357 route product structure diagram
    ACHPOW35723229-25-6 In Stock
Inquiry

Comments (0)